Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

Single needle

Patients will be sampled for a total of 6 consecutive FNA passes with a single EUS-FNA needle (only replaced if the needle has a reduced performance). After completing the 6th pass the endoscopist will be informed by the onsite cytopathologist about the preliminary cytological diagnosis.

PROCEDURE

Multiple needle

Patients will be sampled for a total of 6 consecutive FNA passes, replacing the needle after every 2 passes. After completing the 6th pass the endoscopist will be informed by the onsite cytopathologist about the preliminary cytological diagnosis.

Trial Locations (1)

60637

University of Chicago Medical Center, Chicago

All Listed Sponsors
collaborator

Cook Group Incorporated

INDUSTRY

lead

University of Chicago

OTHER

NCT00548626 - Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer | Biotech Hunter | Biotech Hunter